Springer eBooks may be purchased by end-customers only and are sold without copy protection (DRM free). Instead, all eBooks include personalized watermarks. This means you can read the Springer eBooks across numerous devices such as Laptops, eReaders, and tablets.
You can pay for Springer eBooks with Visa, Mastercard, American Express or Paypal.
After the purchase you can directly download the eBook file or read it online in our Springer eBook Reader. Furthermore your eBook will be stored in your MySpringer account. So you can always re-download your eBooks.
Comprehensive overview, covering epidemiology/prognosis, pathology, immunology, diagnosis and treatment strategies
Prof. Schultheiss is a leading expert in this area
Cardiomyopathy is one of the most frequent causes of heart failure, and a leading entity of cardiac transplantation in the era of modern heart failure regimens. This volume focuses on major advances in inflammatory cardiomyopathy (DCMi) during the past 10 years.
The book is divided up into the following sections: 1. Myocarditis and inflammatory cardiomyopathy – clinical management, epidemiology and prognosis; 2. Animal Models of myocarditis – autoimmunity and viral infection and therapeutic interventions; 3. Alterations of the immune system in human viral and inflammatory cardiomyopathy; 4. Diagnostic concepts of inflammatory and viral cardiomyopathy in endomyocardial biopsies (EMBs) including cardiac magnetic resonance; 5. Conventional and immunomodulatory treatment strategies in inflammatory cardiomyopathy patients.
An international group of authors discusses topics as the histological Dallas criteria for clinical diagnostics, emerging relevance of immunohistological detection of DCMi and detectability of viruses in EMBs, and epidemiology and standard clinical treatment of acute myocarditis and dilated cardiomyopathy patients.
This volume serves as a valuable source for cardiologists and cardiovascular pathologists to update their knowledge on DCMi, a still enigmatic and fascinating cardiovascular disorder, which has made major steps from bench to bedside in the past decade.
Pathogenesis, diagnosis and treatment of pericarditis.- Epidemiology and prognosis of myocarditis and dilated cardiomyopathy: Predictive value of clinical parameters and biopsy findings.- Autoimmune murine myocarditis and immunomodulatory interventions.- Coxsackievirus-induced murine myocarditis and immunomodulatory interventions.- Myocardial proteases and matrix remodeling in acute myocarditis and inflammatory cardiomyopathy.- Molecular genetics of cardiomyopathies and myocarditis.- Pathogenic relevance of autoantibodies in dilated cardiomyopathy.- The role of cytokines in inflammation induced cardiomyopathy: Pathogenesis and therapeutic implications.- Histology and immunohistology of myocarditis.- Immunohistological diagnosis of inflammatory cardiomyopathy and
diagnosis of cardiotropic viral infections.- Cardiac magnetic resonance imaging – A non-invasive approach for the detection of myocardial inflammation – Potentials and limitations.- Clinical management of acute myocarditis and cardiomyopathy.- Immunosuppressive treatment of inflammatory cardiomyopathy patients.- Antiviral interferon-? treatment in patients with chronic viral cardiomyopathy.- Immunoadsorption in dilated cardiomyopathy patients